Annual securities reports (有価証券報告書) filed on EDINET — management narrative only (statistics tables, financial-statement notes, director remuneration and cross-shareholding disclosure are excluded). TSE corporate-governance reports and TDnet are separate documents and are not read here.
Oncolys BioPharma Inc. 4588
| Cost of capital | uses the term cost reduction 「また、銀行借入の実施により資本コストの引き下げを目指します」ManagementAnalysisOfFinancialPositionOperatingResultsAndCashFlowsTextBlock | read (2026-09-01) |
|---|---|---|
| PBR | no mention | matched by rule |
| Metric | no metric named | matched by rule |
| Target | no numeric target | matched by rule |
| Payout | no return language | matched by rule |
For desks: your watchlist through these questions, kept current each filing season. Custom, from $999+.
Reply with your names